FDA Approved: FARESTON — Supplemental Application (Kyowa Kirin, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Fareston (toremifene citrate) submitted by Kyowa Kirin, Inc., resulting in a labeling update for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• FARESTON (toremifene citrate)

Snippet

SUPPL AP for FARESTON (TOREMIFENE CITRATE)